Project Grant T32AI200938
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $201,600 on August 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support an Immunology Training Program. The program establishes a collaboration across three Houston-area institutions—Baylor College of Medicine, University of Texas Health Science Center at Houston, and MD Anderson Cancer Center—to train predoctoral immunology researchers. Four carefully selected...
- The National Institute of Allergy and Infectious Diseases, a division of the Department of Health and Human Services, awarded the University of Maryland, Baltimore $312,537 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 1, 2026, to support the Mechanisms Integrating Nervous and Immune Systems Training Program (MINISTP). The award funds a two-tiered training curriculum designed to prepare three graduate students and two post-doctoral researchers for up to...
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $752,172 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a mechanistic study of an RNA translocase via integrative multi-resolution approach. The research investigates how mycobacteria persist in the host by examining a conserved bifunctional RNA helicase and nuclease enzyme found across mycobacterium species. The enzyme is thought to promote...
- The National Institute of Allergy and Infectious Diseases awarded Baylor University $561,968 on July 7, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the role of microbial-derived indoles in controlling Fusobacterium nucleatum virulence and host immune responses. The research determines the metabolic pathways contributing to indole-3-aldehyde and indole-3-carboxylic acid production in the human gut microbiome using computational gene annotation,...
- The National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, awarded the University of Oklahoma Health Sciences Center $233,001 on August 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support an interdisciplinary training program in immunity and microbial infection. The award funds a five-year training program that will provide predoctoral research training to five trainees per...
- The National Institute of Allergy and Infectious Diseases awarded The University of Texas Southwestern Medical Center $191,987 on June 15, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to establish a postdoctoral research training program in infectious diseases. The UT Southwestern Infectious Diseases Research Training Program supports two postdoctoral physician-scientist trainees annually for two-year training periods. The program recruits physician-scientists...
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $2.361 million on June 15, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop microbiome-based strategies for preventing and treating bacterial infections resistant to antibiotics at mucosal surfaces. The project, titled "Advancing Multimodal Biologics to Combat Antibiotic Resistance at Mucosal Surfaces," encompasses four research projects supported by two...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded $504,547 to The Regents of the University of California, San Francisco (UCSF) on August 6, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855, Project Grant T32AI200899). The award funds the UCSF Immunology Training Program (ITP), which provides structured training to approximately 5–6 graduate students per year (3 per cohort) and 2–3...
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $101,052 for basic research investigating the role of granzyme A in CD8 T cell exhaustion under the Allergy and Infectious Diseases Research program (CFDA 93.855) on October 16, 2026. The funded research examines how CD8 T cells—which directly kill virally infected and cancerous cells—lose effector function when chronically stimulated by persistent antigens in chronic viral infections and cancer. The...
- The National Institute of Allergy and Infectious Diseases awarded William Marsh Rice University $422,698 on February 6, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to explore how the innate immune system shapes the adaptation of emergent and pre-emergent opportunistic pathogens. The research uses a high-throughput approach combining microfluidics, in vitro experimental evolution, and genomic and phenotypic characterization to investigate microbial emergence and...
The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $452,128 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research training in infection and immunity. The award funds the Baylor College of Medicine Research Training in Infection and Immunity program, which will train four MD, MD/PhD, or PhD postdoctoral fellows annually for two years of mentored research training. The program provides a comprehensive curriculum spanning three training tracks—laboratory-based research, patient-based research, and global and public health research—with research focus areas including enteric pathogens, vaccine development and testing, HIV, infection pathogenesis and immunity, tropical medicine and public health, microbiome and functional genomics, and immunology and infections in immunocompromised hosts. Trainees receive structured guidance from a faculty mentorship pool of 33 mentors across all career stages, including both MD and PhD co-mentors, individualized advisory committees, and training in rigor and reproducibility, responsible conduct of research, grant writing, leadership, and laboratory management. The program is based in Houston, Texas, and runs through August 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $452.1k | 9/1/26 |